Johnson & Johnson Cash
Johnson & Johnson (JNJ) had Cash of $2.34 billion as of 2014-12-28, per its 10-K filed 2015-02-24.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2015-02-24
- 2014-12-28: Cash $2.34B.
- 2013-12-29: Cash $2.79B.
- 2012-12-30: Cash $3.03B.
- 2012-01-01: Cash $2.71B.
| Period end | Cash |
|---|---|
| 2014-12-28 | $2.34B 10-K · filed 2015-02-24 |
| 2013-12-29 | $2.79B 10-K · filed 2015-02-24 |
| 2012-12-30 | $3.03B 10-K · filed 2014-02-21 |
| 2012-01-01 | $2.71B 10-K · filed 2013-02-22 |
| 2011-01-02 | $2.29B 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |